HER2 amplification is an oncogenic driver in about 25–30% of uterine serous carcinomas (USC) [44,97,98,99], a subtype almost universally classified as p53abn, but is rare in endometrioid EC. The gene discussed is ERBB2; the disease is endometrial serous adenocarcinoma.